Most insulin users — between 70 and 93 percent, depending on whose figures you use and what part of the world you’re looking at — use an insulin pen, a device developed by Novo Nordisk in the eighties ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Pens for the diabetes drug Ozempic sit on a production line to be packaged at the Danish drugmaker Novo Nordisk's site ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback